The Impact of Iodinated Contrast Agent Administered During Preoperative Computed Tomography Scan on Body Iodine Pool in Patients with Differentiated Thyroid Cancer Preparing for Radioactive Iodine Treatment-Reference-Cited by-同舟云学术

The Impact of Iodinated Contrast Agent Administered During Preoperative Computed Tomography Scan on Body Iodine Pool in Patients with Differentiated Thyroid Cancer Preparing for Radioactive Iodine Treatment

Published:2014-05 Issue:5 Volume:24 Page:872-877
ISSN:1050-7256
Container-title:Thyroid
language:en
Short-container-title:Thyroid

Author:

Sohn Seo Young¹,Choi Ji Hun¹,Kim Na Kyung¹,Joung Ji Young¹,Cho Yoon Young¹,Park Sun Mi¹,Kim Tae Hun¹,Jin Sang Man¹,Bae Ji Cheol¹,Lee Soo Youn²,Chung Jae Hoon¹,Kim Sun Wook¹

Affiliation:

1. Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

2. Department of Laboratory Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/thy.2013.0238

Reference23 articles.

1. Moderate doses of iodide in vivo inhibit cell proliferation and the expression of thyroperoxidase and Na+/I− symporter mRNAs in dog thyroid

2. Iodine content of human tissues after administration of iodine containing drugs or contrast media

3. Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Analysis of 131I Efficacy After Papillary Thyroid Carcinoma Surgery Based on CT Radiomics;The Journal of Clinical Endocrinology & Metabolism;2024-05-27

2. Chapter 2: Evaluation of Solitary Thyroid Nodule;Journal of Head & Neck Physicians and Surgeons;2024-01

3. Role of computed tomography in the evaluation of regional metastasis in well-differentiated thyroid cancer;Frontiers in Radiology;2023-10-31

4. DGN-Handlungsempfehlung (S1-Leitlinie): Radiojodtherapie bei benignen Schilddrüsenerkrankungen (Stand 6/2022 – AWMF-Registernummer: 031-003) – Radiojodtherapie bei benignen Schilddrüsenerkrankungen;Nuklearmedizin - NuclearMedicine;2023-10-23

5. Preoperative Evaluation of Thyroid Cancer: A Review of Current Best Practices;Endocrine Practice;2023-10